Innovation Risk Outstrips Regulators Progress - Horasis USA Meeting 2022
Channel: Horasis Org
Date: 2022-03-06

Innovation comes quickly to test an opportunity, while regulators have to convene meetings to make considered judgements, which takes time. Ought it to be the first and second phase investors who undertake the due diligence of innovators’ consequences?  Would slower innovation reduce the global novelty that in a few cases becomes a true benefit? 
• Emma Arakelyan, Co-founder and Chief Executive Officer, Orion Worldwide Innovations, USA 
Chaired by
• Angela Huang, Founder and President, Tempo Bioscience, USA